Home » Authors » James Etheridge

Articles by James Etheridge

France Biotech Calls For Global Initiatives By European Industry

June 10, 2002

By James Etheridge

French Researchers Discover New Actor In Genome Assembly

June 5, 2002

By James Etheridge

French Researchers Discover New Actor In Genome Assembly

June 5, 2002

By James Etheridge

Euroscreen, Pfizer Enter Deal Centered On CCR5 Receptor

May 29, 2002

By James Etheridge

Genostar Consortium Unveils Genomics, Proteomics Platform

May 29, 2002

By James Etheridge

NicOx Enters Licensing Deal With Axcan Covering NCX 1000

May 29, 2002

By James Etheridge

NicOx Enters Licensing Deal With Axcan Covering NCX 1000

May 29, 2002

By James Etheridge

Genostar Consortium Unveils Genomics, Proteomics Platform

May 29, 2002

By James Etheridge

Euroscreen, Pfizer Enter Deal Centered On CCR5 Receptor

May 29, 2002

By James Etheridge

IDM Receives Approval For Ovarian Cancer Therapy Trial

May 22, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 11, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.